SubHero Banner

ScieGen Pharmaceuticals – Recall of Irbesartan Update

October 30, 2018 - ScieGen Pharmaceuticals announced an update to the consumer-level recall of several lots of irbesartan tablets due to the detection of trace amounts of an unexpected impurity, identified as n-nitrosodiethylamine (NDEA), found in an active pharmaceutical ingredient (API) manufactured by Aurobindo Pharmaceuticals.

Download PDF